AVIDIS SA has a total of 19 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are AmideBio LLC, HEAT BIOLOGICS INC and ARIZEKE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Hill Fergal | 15 |
#2 | Julien Michel | 8 |
#3 | Garnier Laurence | 5 |
#4 | Dumon Laurence | 4 |
#5 | Andreoletti Pierre | 4 |
#6 | Risse Emmanuel | 4 |
#7 | Marchand Jean Baptiste | 3 |
#8 | Fergal Hill | 2 |
#9 | Jullen Michel | 1 |
#10 | Emmanuel Risse | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005077976A2 | Coiled-coil domains from c4b-binding protein | |
WO2005051414A1 | Use of c4bp core region as a cd40 agonist | |
CA2535517A1 | Product comprising a c4bp core protein and a monomeric antigen, and its use | |
EP1664124A2 | Product comprising a c4bp core protein and a monomeric antigen, and its use | |
CA2494971A1 | Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use | |
WO2004020639A2 | Production of multimeric fusion proteins using a c4bp scaffold | |
EP1396537A1 | Treatment of elevated plasma homocysteine |